A detailed history of Parallel Advisors, LLC transactions in Novo Nordisk A S stock. As of the latest transaction made, Parallel Advisors, LLC holds 51,387 shares of NVO stock, worth $5.55 Million. This represents 0.15% of its overall portfolio holdings.

Number of Shares
51,387
Previous 51,263 0.24%
Holding current value
$5.55 Million
Previous $7.32 Million 16.39%
% of portfolio
0.15%
Previous 0.19%

Shares

34 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$119.07 - $145.42 $14,764 - $18,032
124 Added 0.24%
51,387 $6.12 Million
Q2 2024

Aug 08, 2024

BUY
$122.71 - $146.91 $6,749 - $8,080
55 Added 0.11%
51,263 $7.32 Million
Q1 2024

May 06, 2024

BUY
$102.11 - $135.92 $900,916 - $1.2 Million
8,823 Added 20.82%
51,208 $6.58 Million
Q4 2023

Feb 09, 2024

BUY
$87.78 - $105.45 $137,639 - $165,345
1,568 Added 3.84%
42,385 $4.38 Million
Q3 2023

May 20, 2024

BUY
$90.94 - $199.54 $1.88 Million - $4.12 Million
20,657 Added 102.47%
40,817 $3.71 Million
Q3 2023

Nov 13, 2023

BUY
$90.94 - $199.54 $1.88 Million - $4.12 Million
20,657 Added 102.47%
40,817 $3.71 Million
Q2 2023

May 20, 2024

BUY
$155.98 - $172.65 $137,106 - $151,759
879 Added 4.56%
20,160 $3.26 Million
Q2 2023

Aug 04, 2023

BUY
$155.98 - $172.65 $137,106 - $151,759
879 Added 4.56%
20,160 $3.26 Million
Q1 2023

May 20, 2024

SELL
$132.34 - $159.14 $4.23 Million - $5.08 Million
-31,927 Reduced 62.35%
19,281 $3.07 Million
Q1 2023

Apr 25, 2023

BUY
$132.34 - $159.14 $842,211 - $1.01 Million
6,364 Added 49.27%
19,281 $3.07 Million
Q4 2022

Feb 03, 2023

SELL
$102.55 - $135.33 $47,685 - $62,928
-465 Reduced 3.47%
12,917 $1.75 Million
Q3 2022

Nov 10, 2022

SELL
$95.28 - $116.93 $24,010 - $29,466
-252 Reduced 1.85%
13,382 $1.33 Million
Q2 2022

Aug 01, 2022

BUY
$103.24 - $121.81 $21,473 - $25,336
208 Added 1.55%
13,634 $1.52 Million
Q1 2022

Apr 28, 2022

BUY
$93.1 - $112.54 $110,323 - $133,359
1,185 Added 9.68%
13,426 $1.51 Million
Q4 2021

Jan 20, 2022

BUY
$95.88 - $117.08 $55,802 - $68,140
582 Added 4.99%
12,241 $1.37 Million
Q3 2021

Nov 02, 2021

SELL
$84.42 - $106.62 $69,308 - $87,535
-821 Reduced 6.58%
11,659 $1.12 Million
Q2 2021

Aug 06, 2021

BUY
$67.66 - $84.76 $55,007 - $68,909
813 Added 6.97%
12,480 $1.05 Million
Q1 2021

Apr 23, 2021

BUY
$67.06 - $75.82 $22,532 - $25,475
336 Added 2.97%
11,667 $787,000
Q4 2020

Feb 02, 2021

BUY
$63.89 - $73.8 $197,356 - $227,968
3,089 Added 37.48%
11,331 $791,000
Q3 2020

Oct 27, 2020

BUY
$63.69 - $70.22 $83,879 - $92,479
1,317 Added 19.02%
8,242 $572,000
Q2 2020

Jul 16, 2020

BUY
$58.54 - $67.94 $27,455 - $31,863
469 Added 7.26%
6,925 $453,000
Q1 2020

Apr 27, 2020

BUY
$49.46 - $64.78 $4,154 - $5,441
84 Added 1.32%
6,456 $388,000
Q4 2019

Jan 30, 2020

BUY
$49.86 - $58.26 $12,764 - $14,914
256 Added 4.19%
6,372 $369,000
Q3 2019

Nov 01, 2019

SELL
$47.54 - $53.43 $9,793 - $11,006
-206 Reduced 3.26%
6,116 $316,000
Q2 2019

Aug 05, 2019

SELL
$46.79 - $52.47 $3,415 - $3,830
-73 Reduced 1.14%
6,322 $323,000
Q1 2019

May 01, 2019

BUY
$46.36 - $52.63 $36,160 - $41,051
780 Added 13.89%
6,395 $335,000
Q4 2018

Feb 05, 2019

BUY
$41.54 - $47.25 $1,329 - $1,512
32 Added 0.57%
5,615 $258,000
Q3 2018

Nov 01, 2018

SELL
$46.76 - $51.24 $1,309 - $1,434
-28 Reduced 0.5%
5,583 $263,000
Q2 2018

Jul 30, 2018

BUY
$44.29 - $50.42 $18,601 - $21,176
420 Added 8.09%
5,611 $258,000
Q1 2018

May 08, 2018

SELL
$48.49 - $58.14 $6,594 - $7,907
-136 Reduced 2.55%
5,191 $256,000
Q4 2017

Feb 13, 2018

BUY
$47.53 - $53.73 $5,561 - $6,286
117 Added 2.25%
5,327 $286,000
Q3 2017

Nov 15, 2017

BUY
$41.15 - $49.22 $214,391 - $256,436
5,210 New
5,210 $259,000
Q3 2017

Nov 14, 2017

SELL
$41.15 - $49.22 $169,044 - $202,195
-4,108 Closed
0 $0
Q2 2017

Aug 07, 2017

BUY
N/A
4,108
4,108 $174,000

Others Institutions Holding NVO

About NOVO NORDISK A S


  • Ticker NVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,257,289,984
  • Market Cap $244B
  • Description
  • Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...
More about NVO
Track This Portfolio

Track Parallel Advisors, LLC Portfolio

Follow Parallel Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Parallel Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Parallel Advisors, LLC with notifications on news.